SALES COACHING

Breaking the Bias Barrier: Transforming Pharma Rep-HCP Relationships for Mutual Success

Consider this perplexing question: In the world of pharma sales, did healthcare professionals (HCPs) limit their time with sales reps due to genuinely packed schedules, or did decades of unsatisfying interactions with sales reps lead to deliberate disengagement? 

This chicken-or-egg conundrum is a primary challenge facing pharmaceutical sales today. Over time, industry practices and accumulated experiences have shaped HCPs’ perceptions of sales representatives. These perceptions—whether we label them “biases” or “realities”—have created a challenging environment with far-reaching consequences. 

For sales leaders, the task of overcoming decades of formed opinions may seem daunting, but it’s crucial to recognize that you are at the forefront of this transformation. Your role is integral in reimagining the sales approach and focusing on creating high-value experiences for HCPs. With work and determination, you can break this cycle, transforming your sales reps into trusted partners who are there to collaborate with HCPs to improve patient outcomes. 

In this article, we’ll explore practical strategies for elevating customer engagement in pharma sales, fostering partnerships that not only accelerate the adoption of innovative healthcare solutions but also drive sales growth and directly contribute to better patient care. We’ll examine how to transform sales interactions into mutually beneficial exchanges.  

Understanding the Current Landscape

Many HCPs have grown skeptical of pharma sales reps due to outdated engagement strategies. A typical interaction we’ve heard frequently from a client in their “ride-along” with sales reps involves a rehearsed monologue about product features, followed by a direct appeal for prescriptions. It goes something like this:  

“Good morning, Doctor. I have some information about [Product X] I’d like to share with you today.’ [The sales rep then launches into a rehearsed monologue, reciting every feature and benefit they can remember. After this one-sided presentation, they conclude with a direct appeal]: ‘Would you consider prescribing this for your next 10 to 50 patients?” 

This one-directional, transactional approach fails to consider the physician’s specific needs, patient population, prescribing patterns, or the complexities of patient care, leaving HCPs feeling unheard and frankly, massively underwhelmed. 

This disconnect between current sales practices and HCP expectations has significant implications. It not only hampers sales performance but also potentially delays the adoption of innovative treatments that could benefit the HCP’s patients. 

Industry research highlights the importance of this opportunity: 

88% of HCPs said they’d be twice as likely to meet with a rep if the interaction mirrored their best relationship. Not only that, but 35% said having a positive interaction with a rep would make them more likely to meet with others from the company; 41% said they’d be more likely to open emails and listen to a company’s messages (Fierce Pharma). 

To begin to bridge this gap, leaders need to reimagine their sales approach. By creating high-value experiences that address each HCP’s unique challenges, sales reps can evolve from product promoters to trusted partners in improving patient care. 

It’s essential to recognize that in today’s digital age, HCPs have unprecedented access to information. With just a few clicks, they can find basic product details, clinical trial results, and even peer discussions about new treatments. However, this ease of access to information doesn’t make sales representatives expendable. Instead, it raises the bar to create more valuable interactions. Today, HCPs are looking for insights, contextualization, and practical applications that go beyond what they can easily find online themselves. They seek conversations that challenge their thinking, provide new perspectives, and offer solutions tailored to their specific practice challenges. Sales reps must continuously strive to deliver value and exceptional customer experiences (even through highly regulated parameters).  

Strategies for Elevating Customer Experience

To transform these interactions and create meaningful partnerships, pharma companies should focus on the following strategies: 

Building Trust and Credibility

Sales representatives must move beyond simply delivering messages to engaging in meaningful dialogues about patient care and treatment options. This involves: 

• Demonstrating expertise: Showcasing deep scientific knowledge about their products and relevant therapeutic areas.
• Providing value upfront: Offering valuable insights, educational resources, or support to HCPs that go beyond product information (within regulatory and company guidelines).
• Focusing on customer needs: Prioritizing understanding and addressing the specific challenges and objectives of each HCP rather than solely promoting products.

Improving Communication Skills

Effective communication is crucial for meaningful interactions. Sales reps should focus on: 

• Active listening: Truly hearing and acknowledging HCPs’ perspectives and concerns.
• Empathy and understanding: Demonstrating awareness of the challenges faced by HCPs in their daily practice.
• Clear and concise messaging: Communicating the value of products or services in a clear, scientifically accurate manner while respecting the HCP’s time constraints.
• Asking insightful questions: Engaging HCPs in thoughtful dialogue that goes beyond surface-level product discussions 

Ask Insightful Questions

Asking insightful questions is a critical skill that can transform the quality of interactions between sales reps and HCPs. By incorporating insightful questioning, sales reps can: 

• Demonstrate genuine interest in the HCP’s practice and challenges.
• Uncover deeper insights about patient needs and treatment approaches.
• Stimulate meaningful discussions that add value to the HCP’s thought process.
• Position themselves as knowledgeable partners rather than just product promoters.

Examples of insightful questions:

• “What are the most significant challenges you’re facing in managing patients with [specific condition]?” 
• “How do you see the treatment landscape for [specific condition] evolving over the next few years?” 
• “In your experience, what factors most influence patient adherence to treatments for [specific condition]?” 
• “How do you balance the latest clinical guidelines with individual patient needs in your practice?” 

By asking insightful questions, sales reps can engage HCPs in meaningful conversations that not only provide valuable insights but also elevate the interaction beyond a typical sales pitch. “The most effective interactions are those where the healthcare professional responds to questions with statements like ‘I’ve never thought about that’ or ‘You know what? That’s an interesting point.'” 

This approach aligns with the goal of transforming sales reps into trusted partners. It shows that the rep is not just there to deliver information but to engage in a meaningful exchange that can ultimately benefit patient care. Moreover, by prompting HCPs to think about their practices and challenges in new ways, sales reps can create memorable, value-added interactions that HCPs will be more likely to prioritize in their busy schedules. 

Personalize the Sales Approach

One-size-fits-all approaches are no longer effective. 

• Tailor messages to individual customers: Adapt their approach to the specific needs, preferences, and communication styles of individual HCPs.
• Address specific pain points and goals: Understand and directly address the unique challenges and objectives of each HCP to create more relevant and impactful interactions.
• Create a human connection: Build genuine relationships with HCPs to foster more positive and productive interactions.

Leverage Clinical Experience Effectively

While regulatory constraints limit certain types of discussions, sales reps can still effectively leverage clinical experience: 

• Follow up on product usage: When an HCP has prescribed a product, reps can ask about their experience and the patient outcomes they’ve observed (within the scope of the product’s approved uses).
• Explore the HCP’s perception: Discuss how the physician perceives the product’s performance, efficacy, safety, overall satisfaction with the product, and its impact on their practice.
• Focus on approved indications and data: Ensure all discussions remain within the scope of approved product information and clinical data.

Measuring Success and Adapting Strategies

To ensure these strategies are effective, pharma companies should focus on these critical areas of focus for measurement: 

• Impact and time spent: Assess the quality and duration of interactions with HCPs.
• Customer engagement impact: Measure how engagement levels change over time.
• Improvement in interaction skills: Track the development of sales reps’ communication and engagement abilities.

To ensure continuous improvement: 

• Gather feedback: Regularly seek input from HCPs on the value of interactions and areas for improvement.
• Refine approaches: Use feedback and performance data to continuously adapt and improve sales strategies.
• Stay informed: Keep abreast of industry trends, research, and best practices to ensure sales approaches remain current and effective.

In Sum

As the industry continues to evolve, HCPs will continue to seek more value from pharma reps. As sales reps grow into trusted advisors, they create the high-value experiences HCPs crave, resolving the chicken-egg (time-constraint) scenario. 

When HCPs recognize the genuine value in these engagements, they will willingly invest more time because it benefits their practice and patients. This creates a virtuous cycle in which HCPs view pharma reps as true partners in patient care. 

By embracing this approach, pharma sales leaders will drive sales performance while advancing their company’s core mission of improving patient outcomes. 

---

PDG is grateful to have a bench of experts with deep knowledge in this topic area. We especially thank Dan Snyder and Ed Gutshall for their contributions and insights into this article.